These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7026186)

  • 21. Methylphenidate dosing: twice daily versus three times daily.
    Stein MA; Blondis TA; Schnitzler ER; O'Brien T; Fishkin J; Blackwell B; Szumowski E; Roizen NJ
    Pediatrics; 1996 Oct; 98(4 Pt 1):748-56. PubMed ID: 8885956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relative efficacy of methylphenidate (ritalin) and behavior-modification techniques in the treatment of a hyperactive child.
    Wulbert M; Dries R
    J Appl Behav Anal; 1977; 10(1):21-31. PubMed ID: 321410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of methylphenidate on the soft neurological signs of hyperactive children.
    Lerer RJ; Lerer MP
    Pediatrics; 1976 Apr; 57(4):521-5. PubMed ID: 772581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of parent and teacher reports of attention-deficit/hyperactivity disorder symptoms from two placebo-controlled studies of atomoxetine in children.
    Biederman J; Gao H; Rogers AK; Spencer TJ
    Biol Psychiatry; 2006 Nov; 60(10):1106-10. PubMed ID: 16806096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication effects in the classroom: three naturalistic indicators.
    Whalen CK; Henker B; Finck D
    J Abnorm Child Psychol; 1981 Dec; 9(4):419-33. PubMed ID: 7328224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral and stimulant treatment of hyperactive children: a therapy study with methylphenidate probes in a within-subject design.
    Pelham WE; Schnedler RW; Bologna NC; Contreras JA
    J Appl Behav Anal; 1980; 13(2):221-36. PubMed ID: 7380749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of methylphenidate on hyperactive children's ability to sustain attention.
    Charles L; Schain RJ; Zelniker T; Guthrie D
    Pediatrics; 1979 Oct; 64(4):412-8. PubMed ID: 492805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perceptions of methylphenidate effects on hyperactive children's peer interactions.
    Granger DA; Whalen CK; Henker B
    J Abnorm Child Psychol; 1993 Oct; 21(5):535-49. PubMed ID: 8294652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder.
    Bental B; Tirosh E
    J Clin Psychopharmacol; 2008 Feb; 28(1):89-92. PubMed ID: 18204348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prosocial behavior in hyperactive boys: effects of stimulant medication and comparison with normal boys.
    Buhrmester D; Whalen CK; Henker B; MacDonald V; Hinshaw SP
    J Abnorm Child Psychol; 1992 Feb; 20(1):103-21. PubMed ID: 1548391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing treatment tactics with a hyperactive preschool child: stimulant medication and programmed teacher intervention.
    Shafto F; Sulzbacher S
    J Appl Behav Anal; 1977; 10(1):13-20. PubMed ID: 845097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of methylphenidate on prepulse inhibition during attended and ignored prestimuli among boys with attention-deficit hyperactivity disorder.
    Hawk LW; Yartz AR; Pelham WE; Lock TM
    Psychopharmacology (Berl); 2003 Jan; 165(2):118-27. PubMed ID: 12417963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
    Posey DJ; Aman MG; McCracken JT; Scahill L; Tierney E; Arnold LE; Vitiello B; Chuang SZ; Davies M; Ramadan Y; Witwer AN; Swiezy NB; Cronin P; Shah B; Carroll DH; Young C; Wheeler C; McDougle CJ
    Biol Psychiatry; 2007 Feb; 61(4):538-44. PubMed ID: 17276750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does stimulant medication improve the peer status of hyperactive children?
    Whalen CK; Henker B; Buhrmester D; Hinshaw SP; Huber A; Laski K
    J Consult Clin Psychol; 1989 Aug; 57(4):545-9. PubMed ID: 2768616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylphenidate compared with behavioral self-control in attention deficit disorder: preliminary report.
    Anderson EE; Clement PW; Oettinger L
    J Dev Behav Pediatr; 1981 Dec; 2(4):137-41. PubMed ID: 7320203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability and validity of the SKAMP rating scale in a laboratory school setting.
    Wigal SB; Gupta S; Guinta D; Swanson JM
    Psychopharmacol Bull; 1998; 34(1):47-53. PubMed ID: 9564198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis.
    Van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
    Clin Psychol Rev; 2008 Jun; 28(5):783-800. PubMed ID: 18068284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.